Mercado de Polymarket
Prediction market
Track current outcome prices, market depth, volume, liquidity, and recent trades for Prediction market.
Proximo
- Probabilidad
- 64%
- Liquidez
- $31.11K
- Mejor compra
- 1%
- Mejor venta
- 99%
- Spread
- 98%
- Ultimo trade
- 64%
Outcomes
Resultados del mercado
Precio en vivo
Precio y liquidez
Compra, venta, punto medio, spread y profundidad actuales para este resultado.
- Mejor compra
- 1%
- Mejor venta
- 99%
- Punto medio
- 50%
- Spread
- 98%
- Ultimo trade
- 64%
- Profundidad
- 687,82 / 30.419,53
Historial de precios
Esperando historial de precios
Historial no disponible
Compras
| Precio | Tamano |
|---|---|
| 1% | 18.59 |
| 5% | 10 |
| 6% | 8.33 |
| 10% | 9.5 |
| 11% | 113 |
| 32% | 14.5 |
| 50% | 30 |
| 54% | 16.66 |
Ventas
| Precio | Tamano |
|---|---|
| 99% | 18.000 |
| 98% | 10,01 |
| 97% | 200 |
| 96% | 6300 |
| 95% | 2889 |
| 94% | 8,09 |
| 93% | 300 |
| 85% | 1500 |
Trades
Trades recientes
Latest visible trades for this market.
- Will Johnson & Johnson (JNJ) Q2 Innovation Medicine revenue be above $16.2B?No 36% 20 shares
- Will Johnson & Johnson (JNJ) Q2 Innovation Medicine revenue be above $16.2B?Yes 63% 43 shares
- Will Johnson & Johnson (JNJ) Q2 Innovation Medicine revenue be above $16.2B?Yes 63% 30 shares
- Will Johnson & Johnson (JNJ) Q2 Innovation Medicine revenue be above $16.2B?Yes 63% 19 shares
- Will Johnson & Johnson (JNJ) Q2 Innovation Medicine revenue be above $16.2B?Yes 63% 52.31 shares
- Will Johnson & Johnson (JNJ) Q2 Innovation Medicine revenue be above $16.2B?No 36% 6.24 shares
- Will Johnson & Johnson (JNJ) Q2 Innovation Medicine revenue be above $16.2B?Yes 65% 44.91 shares
- Will Johnson & Johnson (JNJ) Q2 Innovation Medicine revenue be above $16.2B?Yes 65% 25 shares
- Will Johnson & Johnson (JNJ) Q2 Innovation Medicine revenue be above $16.2B?Yes 65% 53.12 shares
- Will Johnson & Johnson (JNJ) Q2 Innovation Medicine revenue be above $16.2B?No 13% 28.06 shares
- Will Johnson & Johnson (JNJ) Q2 Innovation Medicine revenue be above $16.2B?Yes 93.7% 43.13 shares
- Will Johnson & Johnson (JNJ) Q2 Innovation Medicine revenue be above $16.2B?Yes 87% 19.99 shares